Aclaris Therapeutics to Participate in the Evercore ISI 3rd Annual HealthCONx Conference

Rhea-AI Summary

Aclaris Therapeutics, Inc. (NASDAQ: ACRS) announced its participation in a virtual fireside chat at the Evercore ISI 3rd Annual HealthCONx Conference on December 2, 2020, at 7:30 a.m. ET. Management will also be available for one-on-one virtual meetings on December 1 and 2. Investors can access a live audio webcast of the event through the company's website, with an archived version available for 30 days. Aclaris is focused on developing novel drug candidates for immuno-inflammatory diseases, supported by a robust R&D platform.

WAYNE, Pa., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that management will participate in a virtual fireside chat at the Evercore ISI 3rd Annual HealthCONx Conference on Wednesday, December 2, 2020 at 7:30 a.m. ET. Management will be available December 1st and 2nd throughout the day for virtual one-on-one meetings.

A live audio webcast of the fireside chat may be accessed through the Events page under the Investors section of Aclaris’ website, www.aclaristx.com. An archived version of the webcast will be available for 30 days.

About Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of drug candidates powered by a robust R&D engine exploring protein kinase regulation. For additional information, please visit www.aclaristx.com.

Aclaris Contact

investors@aclaristx.com

FAQ

When will Aclaris Therapeutics participate in the Evercore ISI 3rd Annual HealthCONx Conference?

Aclaris Therapeutics will participate in the conference on December 2, 2020, at 7:30 a.m. ET.

How can I access the Aclaris Therapeutics fireside chat?

You can access the live audio webcast of the fireside chat on Aclaris' Events page under the Investors section of their website.

What is the focus of Aclaris Therapeutics?

Aclaris Therapeutics focuses on developing novel drug candidates for immuno-inflammatory diseases.

Will there be a recording of the Aclaris fireside chat available?

Yes, an archived version of the webcast will be available for 30 days after the event.

What dates will Aclaris management be available for one-on-one meetings?

Aclaris management will be available for one-on-one virtual meetings on December 1 and 2, 2020.